ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,267.84
      -0.74%
      US Tech 100
      18,130.80
      -0.54%
      Dow Jones
      39,065.26
      -1.53%
      Brent Oil
      81.315
      -0.26%
      Bitcoin
      67,802.12
      -1.88%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Cryptocurrencies
      4. COIN
      5. (Cryptocurrency:BALLBTC)

      6. (Cryptocurrency:BALLBTC) News

      BALLBTC

      (BALLBTC)

      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      05/23/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PODDInsulet Corporation
      05/23/20245:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BECNBeacon Roofing Supply Inc
      05/23/20245:06PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
      05/23/20245:05PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:HBIHanesbrands Inc
      05/23/20245:05PMEdgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:NCNOnCino Inc
      05/23/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRMSalesforce Inc
      05/23/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PODDInsulet Corporation
      05/23/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRVAPrivia Health Group Inc
      05/23/20245:05PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TCPCBlackRock TCP Capital Corporation
      05/23/20245:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
      05/23/20245:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CADLCandel Therapeutics Inc
      05/23/20245:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      05/23/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRVAPrivia Health Group Inc
      05/23/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XELXcel Energy Inc
      05/23/20245:05PMBusiness WireAulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
      05/23/20245:05PMGlobeNewswire Inc.Elcora Announces Share ConsolidationTSXV:ERAElcora Advanced Materials Corp
      05/23/20245:05PMGlobeNewswire Inc.Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024NASDAQ:AFMDAffimed NV
      05/23/20245:05PMBusiness WireBristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research PlatformsNYSE:BMYBristol Myers Squibb Co
      05/23/20245:05PMPR Newswire (US)EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001, at the Upcoming 2024 ASCO Annual Meeting
      05/23/20245:05PMPR Newswire (US)Landmark Study from Mercy BioAnalytics and University College London Demonstrates Significant Improvement Over CA125 and Ultrasound for Ovarian Cancer Screening
      05/23/20245:05PMPR Newswire (US)IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      05/23/20245:05PMPR Newswire (US)ALIMENTATION COUCHE-TARD TO RELEASE RESULTS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2024 ON JUNE 25, 2024TSX:ATDAlimentation Couche Tard Inc
      05/23/20245:05PMPR Newswire (Canada)ALIMENTATION COUCHE-TARD TO RELEASE RESULTS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2024 ON JUNE 25, 2024TSX:ATDAlimentation Couche Tard Inc
      05/23/20245:05PMGlobeNewswire Inc.FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) at the 2024 American Society of Clinical OncologyNASDAQ:FGENFibroGen Inc
      05/23/20245:05PMPR Newswire (Canada)ALIMENTATION COUCHE-TARD DIFFUSERA LE 25 JUIN PROCHAIN LES RÉSULTATS DE SON QUATRIÈME TRIMESTRE ET DE SON EXERCICE 2024TSX:ATDAlimentation Couche Tard Inc
      05/23/20245:05PMBusiness WireTelevisaUnivision Announces Pricing of $1.0 Billion Debt
      05/23/20245:05PMGlobeNewswire Inc.Elcora Announces Share ConsolidationELM
      05/23/20245:05PMGlobeNewswire Inc.Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual MeetNASDAQ:CMPXCompass Therapeutics Inc
      05/23/20245:05PMGlobeNewswire Inc.Cogent Biosciences Appoints Cole Pinnow as Chief Commercial OfficerNASDAQ:COGTCogent Biosciences Inc
      05/23/20245:05PMBusiness WireBicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC